Abstract

Gastrin is a pro-proliferative, anti-apoptotic hormone with a central role in acid secretion in the gastric mucosa and a long-standing association with malignant progression in transgenic mouse models. However, its exact role in human gastric malignancy requires further validation. Gastrin expression is tightly regulated by two closely associated hormones, somatostatin and gastrin-releasing peptide, and aspects of their interaction may be deregulated during progression to gastric adenocarcinoma. Furthermore, agonists and antagonists of the receptors for all three hormones have shown modest clinical efficacy against gastric adenocarcinoma, which might provide useful information on the future combined use of these agents.

Author affiliations

1. Academic Unit of Cancer Studies, University of Nottingham, Nottingham, NG7 2UH, UK.

Correspondence to: Susan A. Watson¹ Email: sue.watson@nottingham.ac.uk

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.